Compounds > arbekacin

arbekacin and Bacterial Infections, Gram-Negative

arbekacin has been researched along with Bacterial Infections, Gram-Negative in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Albano, M; Fleischmann, WA; Greenwood-Quaintance, KE; Patel, R1
Anandan, S; Balaji, V; Falagas, ME; Rajenderan, S; Sahni, RD; Tansarli, GS1
Hamada, Y; Koyama, I; Kuroyama, M; Sunakawa, K; Tamura, K; Yago, K1
Arakawa, Y; Doi, Y; Kurokawa, H; Wachino, J; Yamane, K1
Arakawa, Y; Ishikawa, S; Kai, K; Kato, H; Kimura, K; Konda, T; Ozawa, Y; Shibata, N; Shibayama, K; Suzuki, S; Wachino, J; Yamane, K1
Chong, Y; Kim, CK; Lee, H; Lee, J; Lee, K; Roh, KH; Yong, D; Yum, JH1

Other Studies

6 other study(ies) available for arbekacin and Bacterial Infections, Gram-Negative

ArticleYear
In vitro activity of arbekacin against multidrug-resistant gram-negative bacilli.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2021, Volume: 54, Issue:6

    Topics: Anti-Bacterial Agents; Dibekacin; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests

2021
Determination of MIC distribution of arbekacin, cefminox, fosfomycin, biapenem and other antibiotics against gram-negative clinical isolates in South India: a prospective study.
    PloS one, 2014, Volume: 9, Issue:7

    Topics: Acinetobacter; Anti-Bacterial Agents; Cephamycins; Dibekacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Fosfomycin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; India; Klebsiella; Microbial Sensitivity Tests; Prospective Studies; Pseudomonas aeruginosa; Thienamycins

2014
Clinical efficacy of arbekacin for Gram-negative bacteria.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2011, Volume: 17, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Coinfection; Dibekacin; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections

2011
Global spread of multiple aminoglycoside resistance genes.
    Emerging infectious diseases, 2005, Volume: 11, Issue:6

    Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Dibekacin; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Global Health; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Methyltransferases; Microbial Sensitivity Tests; RNA, Ribosomal, 16S

2005
16S rRNA methylase-producing, gram-negative pathogens, Japan.
    Emerging infectious diseases, 2007, Volume: 13, Issue:4

    Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Japan; Methyltransferases; Microbial Sensitivity Tests; RNA, Ribosomal, 16S

2007
[In vitro activity of arbekacin against clinical isolates of Staphylococcus species and gram-negative bacilli].
    The Korean journal of laboratory medicine, 2007, Volume: 27, Issue:4

    Topics: Anti-Bacterial Agents; Dibekacin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus

2007